Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, April 02, 2014
INC Research, LLC, a therapeutically focused global clinical research organization (CRO) with a Trusted Process® for delivering reliable results, today announced it will feature three senior leaders, including CEO Jamie Macdonald, at this year’s ...
read more
Tuesday, September 10, 2013
INC Research, a therapeutically focused global clinical research organization (CRO) with a Trusted Process® for delivering reliable results, today announced it is the first global CRO to implement the Clinical Research Monitor Accreditation program, ...
read more
INC Research, LLC, a therapeutically focused clinical research organization (CRO) with a Trusted Process® for delivering reliable results, today announced Christopher L. Gaenzle has joined the Company as its general counsel. Gaenzle will be part of ...
read more
Wednesday, March 12, 2014
INC Research, a therapeutically focused global clinical research organization (CRO) with a Trusted Process® for delivering reliable results, today announced the appointment of Jane Winter as Senior Vice President, Global Consulting.
read more
Inato has released its anticovid platform, a comprehensive, central repository for all existing clinical trials for SARS-CoV 2.
read more
Wednesday, November 12, 2014
Implandata Ophthalmic Products GmbH (Implandata) an ophthalmic surgical product and e-Health start-up company announces the closing of a €3M Series B-Round. Born2Grow Venture Partners, a private fund based in Heilbronn/Germany joins in as new ...
read more
Monday, September 23, 2019
Immutep will receive a milestone payment from GSK of £4 million related to the first patient being dosed in GSK’s Phase II clinical trial evaluating GSK2831781 for ulcerative colitis.
read more
ImmunoPrecise and LiteVax announced a preclinical study to analyze IPA's novel SARS-CoV-2 vaccine candidates, has been granted funding by TRANSVAC2.
read more
Monday, November 11, 2013
IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based generic topical pharmaceutical company, today announced it has received formal approval from the U.S. Food and Drug Administration (FDA) of its supplemental filing for the site transfer of ...
read more
ICON plc, (NASDAQ: ICLR) a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that its Firecrest training meets TransCelerate BioPharma Inc.’s minimum criteria for ...
read more
Tuesday, February 05, 2013
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has agreed, subject to certain closing conditions, to acquire the Clinical Trial Services ...
read more
Wednesday, April 02, 2014
ICON plc, (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has agreed, subject to certain closing conditions, to acquire Aptiv Solutions ...
read more
Thursday, October 06, 2022
ICON plc has been selected by the US Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) in the Department of Health and Human Services (HHS), to execute an anthrax...
read more
Saturday, September 25, 2021
The Tánaiste and Minister for Enterprise, Trade and Employment, Leo Varadkar TD announced that ICON, a Dublin-based global provider of drug development and commercialisation services to pharmaceutical, biotechnology and medical device industries, has...
read more
ICON plc announced the completion of its acquisition of PRA Health Sciences. The combined company will retain the name ICON and will bring together 38,000 employees across 47 countries, creating the world’s most advanced healthcare intelligence and ...
read more